Global Facial Injectables Market, By Product Type (Dermal Fillers (Hyaluronic Acid Fillers, Collagen Fillers and Synthetic Fillers) and Anti-wrinkle Injections (Botulinum Toxin A and Poly-L-lactic acid (PLLA)), By Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others), By End User (Hospitals, Beauty Clinics, and Dermatology Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 5,088.5 million in 2019, and is projected to exhibit a CAGR of 14.9% over the forecast period (2019 - 2027). Key players are adopting collaborations and product launches strategies in order to address the unmet aesthetic needs thereby, providing physicians with new and better options, augmenting growth of facial injectables market. For instance, in March 2017, Galderma, provider of medical solutions for skin health, collaborated with Colorescience to expand its skincare solutions that can be used in conjunction with conventional facial injectable aesthetic treatments. Under this collaboration, Galderma and Colorescience are offering comprehensive products to aesthetic healthcare professionals who are looking for innovative skincare solutions.
Furthermore, in March 2017, Allergan Plc. received the U.S. Food and Drug Administration (FDA) approval for Juvederm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds in adults over the age of 21, in the U.S. The product was introduced or launched in the Europe market in 2013 In May 2018, Lsf Farma Ltd. launched Bliss dermal fillers in the U.K. market. The variations of the Bliss dermal filler include Bliss Soft with an 18 mg/ml concentration, Bliss Derm with a 23 mg/ml concentration, and Bliss Ultra with a concentration of 26 mg/ml. The three products are used to alter the dermal skin tissues, to lift and contour, giving immediate and durable results. The product was launched in India, Europe, and Turkey in November 2017.
Browse 36 Market Data Tables and 37 Figures spread through 182 Pages and in-depth TOC on "Facial Injectables Market, By Product Type (Dermal Fillers (Hyaluronic Acid Fillers, Collagen Fillers and Synthetic Fillers) and Anti-wrinkle Injections(Botulinum Toxin A and Poly-L-lactic acid (PLLA)), By Application (Wrinkle Reduction, Facelift, Lip Enhancement and Others), By End User (Hospitals, Beauty Clinics and Dermatology Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027"
To know the latest trends and insights related to Facial Injectables Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/facial-injectables-market-1329
Various organizations are conducting educational programs, scientific meetings to provide knowledge about latest research, to increase awareness among patients and plastic surgeons, which is expected to facilitate the market growth. For instance, the International Society of Aesthetic Plastic Surgery (ISAPS) is a professional organization for board-certified aesthetic plastic surgeons, and is dedicated to promoting excellence in the field of aesthetic plastic surgery globally. The ISAPS conducts instructional courses, symposia, and educational programs, and members of ISAPS have access to advanced techniques such as botulinum toxin and dermal fillers. Moreover, the American Academy of Facial Esthetics (AAFE) provides information about non-surgical and non-invasive facial injectable techniques to healthcare professionals worldwide through courses. AAFE is also committed to providing the best possible outcomes in areas of facial esthetics and facial pain treatment.
Key Takeaways of the Facial Injectables Market:
- The global facial injectables market is expected to expand at a CAGR of 14.9% over the forecast period (2019–2027), owing to increasing launches and FDA approvals of novel products
- Among product type, the dermal fillers segment is expected to hold major revenue share in 2027. The popularity of dermal fillers is increasing rapidly as they rejuvenate and enhance aesthetic improvement with the advantages of quick, relatively inexpensive, and increasingly longer-lasting results for facial wrinkles and deeper folds.
- Major players operating in the global facial injectables market include Allergan plc., Galderma S.A., Medytox Inc., SciVision Biotech Inc., Croma-Pharma GmbH, Anika Therapeutics, Inc., Merz Pharmaceuticals, Sinclair Pharma plc, Suneva Medical, Inc. and Zimmer MedizinSysteme GmbH.
Contact Us